Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.200 | None | 0.979 | 48 | 51 | 1993 | 2018 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.200 | None | 1.000 | 15 | 6 | 1990 | 2018 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.170 | None | 0.875 | 8 | 3 | 2009 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2002 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.070 | None | 1.000 | 7 | 2 | 1996 | 2017 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1998 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2000 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.140 | None | 0.800 | 5 | 8 | 2009 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1991 | 2018 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2000 | 2019 | |||||||||
|
hepatic and glial cell adhesion molecule | 0.621 | 0.500 | 0.87 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2010 | 2015 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1996 | 2000 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2005 | 2019 | ||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2000 | 2019 | |||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2018 | ||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2015 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2018 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.420 | None | 1.000 | 3 | 1 | 2001 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.120 | None | 0.667 | 3 | 8 | 2012 | 2016 | ||||||||
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2019 | ||||||||
|
paired box 5 | 0.487 | 0.654 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2006 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.120 | None | 0.667 | 3 | 4 | 2000 | 2016 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2008 | ||||||||
|
chromosome 17 open reading frame 97 | 0.548 | 0.577 | 4.8E-06 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2000 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2019 |